U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07944859) titled 'Impact of Advanced Parkinson Therapies on Clinical Status: Deep Brain Stimulation and Foslevodopa/Foscarbidopa' on June 24.

Brief Summary: The goal of this observational study is to learn how treatment with selected advanced therapies for Parkinson's disease affect disease motor symptoms, cognition, body weight, body composition and inflammatory biomarkers in people with advanced Parkinson's disease.

The main questions it aims to answer are:

* How do clinical symptoms, cognitive function, body composition and blood biomarkers change during the first 12 months after starting the treatment?

* Are there differences in outcomes betwe...